Key result
The BVS everolimus-eluting PLLA stent was safe at 2 years in patients with simple lesions, with suggestions of luminal enlargement and return of vasomotion.
Design
Review
Authors
Loading...
Supports continued BVS evaluation in simple lesions; leaves open need for randomized data on durability and complex disease.
Bioabsorbable coronary stents offer the theoretical advantage of avoiding late thrombosis by disappearing after vessel healing, with early clinical data showing safety and potential return of normal vessel function.
Ormiston et al. (2009) conducted a review in Coronary artery disease requiring PCI. Bioabsorbable coronary stents (BVS everolimus-eluting PLLA stent) was evaluated. The BVS everolimus-eluting PLLA stent was safe at 2 years in patients with simple lesions, with suggestions of luminal enlargement and return of vasomotion.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: